Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Lynde

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Allergy and Clinical Immunology|November 13, 2025
Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study resultsDiamant Thaçi, Vivian Laquer, Charles Lynde, et al.
JAAD International|November 24, 2021
The Personalised Acne Care Pathway-Recommendations to guide longitudinal management from the Personalising Acne: Consensus of ExpertsJerry Tan, Andrew Alexis, Hilary Baldwin, et al.
JAAD International|November 24, 2021
Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts panelJerry Tan, Andrew Alexis, Hilary Baldwin, et al.
Journal of Cutaneous Medicine and Surgery|July 11, 2014
A consensus on acne management focused on specific patient featuresCharles Lynde, Jerry Tan, Anneke Andriessen, et al.
Journal of Cutaneous Medicine and Surgery|March 12, 2019
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi StudyChristine Fahim, Ben Whan Kim, Marc Bourcier, et al.
Journal of the American Academy of Dermatology|October 18, 2023
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trialJoseph F Merola, Lawrence Charles Parish, Lyn Guenther, et al.
Journal of the American Academy of Dermatology|June 1, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosaceaMartin Schaller, Lajos Kemény, Blanka Havlickova, et al.
Scientometrics|April 10, 2023
Measuring h-index and scholarly productivity in academic dermatology in CanadaMarleine Azar, Francois Lagacé, Anastasiya Muntyanu, et al.
The Journal of Rheumatology|July 17, 2015
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity InitiativeCamille Roubille, Vincent Richer, Tara Starnino, et al.
Annals of the Rheumatic Diseases|March 11, 2015
Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr BoersCamille Roubille, Vincent Richer, Tara Starnino, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Allergy and Clinical Immunology|November 13, 2025
Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study resultsDiamant Thaçi, Vivian Laquer, Charles Lynde, et al.
JAAD International|November 24, 2021
The Personalised Acne Care Pathway-Recommendations to guide longitudinal management from the Personalising Acne: Consensus of ExpertsJerry Tan, Andrew Alexis, Hilary Baldwin, et al.
JAAD International|November 24, 2021
Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts panelJerry Tan, Andrew Alexis, Hilary Baldwin, et al.
Journal of Cutaneous Medicine and Surgery|July 11, 2014
A consensus on acne management focused on specific patient featuresCharles Lynde, Jerry Tan, Anneke Andriessen, et al.
Journal of Cutaneous Medicine and Surgery|March 12, 2019
Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi StudyChristine Fahim, Ben Whan Kim, Marc Bourcier, et al.
Journal of the American Academy of Dermatology|October 18, 2023
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trialJoseph F Merola, Lawrence Charles Parish, Lyn Guenther, et al.
Journal of the American Academy of Dermatology|June 1, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosaceaMartin Schaller, Lajos Kemény, Blanka Havlickova, et al.
Scientometrics|April 10, 2023
Measuring h-index and scholarly productivity in academic dermatology in CanadaMarleine Azar, Francois Lagacé, Anastasiya Muntyanu, et al.
The Journal of Rheumatology|July 17, 2015
Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity InitiativeCamille Roubille, Vincent Richer, Tara Starnino, et al.
Annals of the Rheumatic Diseases|March 11, 2015
Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr BoersCamille Roubille, Vincent Richer, Tara Starnino, et al.
Pageof 15